1172297-96-9 Usage
Uses
Used in Pharmaceutical Industry:
4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride is used as an intermediate in the synthesis of quinoxaline derivatives. These derivatives are known as GPR6 modulators, which are being explored for their potential therapeutic applications. 4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride plays a pivotal role in the development of new drugs targeting the GPR6 receptor, which is implicated in various physiological processes and diseases.
As a GPR6 Modulator:
4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride is used in the development of GPR6 modulators for therapy. GPR6 is a G protein-coupled receptor that has been associated with the regulation of various physiological functions, including glucose homeostasis, energy metabolism, and bone remodeling. Modulating the activity of GPR6 has the potential to offer therapeutic benefits in treating conditions such as diabetes, obesity, and osteoporosis.
In Drug Discovery and Development:
4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride is utilized in drug discovery and development processes to create novel therapeutic agents with improved efficacy and safety profiles. Its unique structure allows for the design of molecules that can specifically target the GPR6 receptor, leading to the development of drugs with fewer side effects and better pharmacological properties.
In Preclinical Research:
4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride is also used in preclinical research to evaluate the potential therapeutic effects of GPR6 modulators. Researchers use 4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride to investigate the mechanisms of action, pharmacokinetics, and pharmacodynamics of quinoxaline derivatives, providing valuable insights into their potential use in clinical settings.
Overall, 4-[(2,5-difluorophenyl)carbonyl]piperidine hydrochloride is a versatile and essential compound in the pharmaceutical industry, playing a significant role in the development of innovative therapeutic agents targeting the GPR6 receptor for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1172297-96-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,2,2,9 and 7 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1172297-96:
(9*1)+(8*1)+(7*7)+(6*2)+(5*2)+(4*9)+(3*7)+(2*9)+(1*6)=169
169 % 10 = 9
So 1172297-96-9 is a valid CAS Registry Number.
